Peer review process
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.
Read more about eLife’s peer review process.Editors
- Reviewing EditorJoshua CorbinChildren's National Hospital, Washington, United States of America
- Senior EditorSacha NelsonBrandeis University, Waltham, United States of America
Reviewer #1 (Public Review):
Summary:
The manuscript by Ozcan et al., presents compelling evidence demonstrating the latent potential of glial precursors of the adult cerebral cortex for neuronal reprogramming. The findings substantially advance our understanding of the potential of endogenous cells in the adult brain to be reprogrammed. Moreover, they describe a molecular cocktail that directs reprogramming toward corticospinal neurons (CSN).
Strengths:
Experimentally, the work is compelling and beautifully designed, with no major caveats. The main conclusions are fully supported by the experiments. The work provides a characterization of endogenous progenitors, genetic strategies to isolate them, and proof of concept of exploiting these progenitors' potential to produce a specific desired neuronal type with "a la carte" combination of transcription factors.
Weaknesses:
Some issues need to be addressed or clarified before publication. The manuscript requires editing. It is dense and rich in details while in other parts there are a few mistakes.
Reviewer #2 (Public Review):
Summary:
Here the authors show a novel direct neuronal reprogramming model using a very pure culture system of oligodendrocyte progenitor cells and demonstrate hallmarks of corticospinal neurons to be induced when using Neurogenin2, a dominant-negative form of Olig2 in combination with the CSN master regulator Fezf2.
Strengths:
This is a major achievement as the specification of reprogrammed neurons towards adequate neuronal subtypes is crucial for repair and still largely missing. The work is carefully done and the comparison of the neurons induced only by Neurogenin 2 versus the NVOF cocktail is very interesting and convincingly demonstrates a further subtype specification by the cocktail.
Weaknesses:
As carefully as it is done in vitro, the identity of projection neurons can best be assessed in vivo. If this is not possible, it could be interesting to co-culture different brain regions and see if these neurons reprogrammed with the cocktail, indeed preferentially send out axons to innervate a co-cultured spinal cord versus other brain region tissue.
Reviewer #3 (Public Review):
Summary:
Ozkan, Padmanabhan, and colleagues aim to develop a lineage reprogramming strategy towards generating subcerebral projection neurons from endogenous glia with the specificity needed for disease modelling and brain repair. They set out by targeting specifically Sox6-positive NG2 glia. This choice is motivated by the authors' observation that the early postnatal forebrain of Sox6 knockout mice displays marked ectopic expression of the proneural transcription factor (TF) Neurog2, suggesting a latent neurogenic program may be derepressed in NG2 cells, which normally express Sox6. Cultured NG2 glia transfected with a construct ("NVOF") encoding Neurog2, the corticofugal neuron-specifying TF Fezf2, and a constitutive repressor form of Olig2 are efficiently reprogrammed to neurons. These acquire complex morphologies resembling those of mature endogenous neurons and are characterized by fewer abnormalities when compared to neurons induced by Neurog2 alone. NVOF-induced neurons, as a population, also express a narrower range of cortical neuron subtype-specific markers, suggesting narrowed subtype specification, a potential step forward for Neurog2-driven neuronal reprogramming. Comparison of NVOF- and Neurog2-induced neurons to endogenous subcerebral projection neurons (SCPN) also indicates Fezf2 may aid Neurog2 in directing the generation of SCPN-like neurons at the expense of other cortical neuronal subtypes.
Strengths:
The report describes a novel, highly homogeneous in vitro system amenable to efficient reprogramming. The authors provide evidence that Fezf2 shapes the outcome of Neurog2-driven reprogramming towards a subcerebral projection neuron identity, consistent with its known developmental roles. Also, the use of the modified RNA for transient expression of Neurog2 is very elegant.
Weaknesses:
The molecular characterization of NVOF-induced neurons is carried out at the bulk level, therefore not allowing to fully assess heterogeneity among NVOF-induced neurons. The suggestion of a latent neurogenic potential in postnatal cortical glia is only partially supported by the data from the Sox6 knockout. Finally, some of the many exciting implications of the study remain untested.
Discussion:
The study has many exciting implications that could be further tested. For example, an ultimate proof of the subcerebral projection neuron identity would be to graft NVOF cells into neonatal mice and study their projections. Another important implication is that Sox6-deficient NG2 glia may not only express Neurog2 but activate a more complete neurogenic programme, a possibility that remains untested here. Also, is the subcerebral projection neuron dependent on the starting cell population? Could other NG2 glia, not expressing Sox6, also be co-axed by the NVOF cocktail into subcerebral projection neurons? And if not, do they express other (Sox) transcription factors that render them more amenable to reprogramming into other cortical neuron subtypes? The authors state that Sox6-positive NG2 glia are a quiescent progenitor population. Given that NG2 glia is believed to undergo proliferation as a whole, are Sox6-positive NG2 glia an exception from this rule? Finally, the authors seem to imply that subcerebral projection neurons and Sox6-positive NG2 glia are lineage-related. However, direct evidence for this conjecture seems missing.